- JP-listed companies
- TOWA PHARMACEUTICAL CO.,LTD.
- Financials
- EBITDA margin (%)
TOWA PHARMACEUTICAL CO.,LTD. (4553)
Market cap
¥219.2B
P/E ratio
11.8x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
| Period End | EBITDA margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 15 | +9.16% |
| Mar 31, 2024 | 13.7 | +45.06% |
| Mar 31, 2023 | 9.5 | -46.59% |
| Mar 31, 2022 | 17.7 | -7.23% |
| Mar 31, 2021 | 19.1 | -13.66% |
| Mar 31, 2020 | 22.1 | -4.31% |
| Mar 31, 2019 | 23.1 | +9.04% |
| Mar 31, 2018 | 21.2 | +21.34% |
| Mar 31, 2017 | 17.5 | -22.26% |
| Mar 31, 2016 | 22.5 | -4.51% |
| Mar 31, 2015 | 23.5 |